Molecular Diagnostics Industry Overview

• Publication date: July 2009
• Report size: 43 pages

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing industry , driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) industry , molecular diagnostics industry is one of the two growth drivers of the IVD market . In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very sma...

Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing industry , driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) industry , molecular diagnostics industry is one of the two growth drivers of the IVD market .

In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases.

Molecular diagnostics holds immense business potential as it is based on the intention of identifying viruses and infectious diseases more accurately at an earlier stage than currently possible. Molecular diagnostics has also emerged as a potential business opportunity as diagnostics businesses generally fetch higher returns of investment than pharmaceutical and other biotech businesses.

The molecular diagnostics market is growing on the path of continuous innovation and changing technological base and this is creating new opportunities and applications. The major factors that will drive the growth of this market includes the increasing incidences of various chronic diseases, increasing number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostics tests. Molecular diagnostics or MDx is the fastest growing sector of the IVD industry , also because of the innovation in the market resulting in the advent of new technologies for genetic testing, faster screening and more precise detection.

The report titled “Molecular Diagnostics Market : Trends and Opportunities” analyzes the molecular diagnostics sector of IVD market . The study explores the potential business opportunities that exist in the molecular diagnostics market . Further, factors that are driving the growth of the market have been assessed. Also, major market trends have been outlined. The report analyzes the level of competition in the molecular diagnostics market and also profiles the leading players underlining their sales and business strategies.

Further, we have predicted the future growth of the molecular diagnostics market by combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings. We employed various significant variables that have an impact on this market and created regression models with SPSS to determine the future direction of the market .

Pharmaceutical Industry in India

I. Molecular Diagnostics: An Overview

I. 1 An Introduction to Molecular Diagnostics
I. 2 Market Background
I. 3 IVD Industry : An Analysis

II. Molecular Diagnostics: Industry Data

II. 1 Market Value and Growth Rate
II. 2 Segment Analysis

III. Industry Opportunities

HPV – a potential growth opportunity
India – an emerging industry for molecular diagnostics
HCV sector – a major contributor to MDx growth

IV. Market Drivers

High returns on investment (ROI)
Growth in US cancer molecular diagnostics industry
Macro-environment favoring genetic testing market
Applied Testing Industry
Growth potential in sepsis diagnosis

V. Industry Trends

Higher price of MDx compared to traditional tests
Growth of automation solutions
Leading molecular tests conducted in the US
Reimbursement for molecular diagnostics tests?
Blood screening and STD industry
Multiplex Platforms

VI. Competitive Landscape

VII. Industry Player Profiles

VII. 1 Roche Diagnostics
Company Description
Sales Analysis
Business Strategies

VII. 2 Qiagen
Company Description
Sales Analysis
Business strategies

VII. 3 Abbott
Company Description
Sales Analysis
Business Strategies

VII. 4 GenProbe
Company Description
Sales Analysis
Business Strategies


VIII. Industry Outlook

VIII. 1 Industry Projection
VIII. 2 Projection Methodology
VIII. II. 1 Dependent and Independent Variables
VIII. II. 2 Correlation Analysis
VIII. II. 3 Regression Analysis

List of Figures

Figure I. 1: In Vitro Diagnostic (IVD) Segments
Figure I. 2: Global IVD Industry Value – 2006 – 2008 & 2012E
Figure I. 3: IVD Industry – Region-wise Breakup (2008)
Figure I. 4: IVD Industry – Segment Breakup (2008)
Figure I. 5: Segment-wise Global IVD Industry Growth, from 2007 to 2012 E
Figure I. 6: CAGR of Global IVD Industry sectors , from 2004 to 2009 E
Figure II. 1: Global Molecular Diagnostics Industry Value : 2005 - 2008
Figure II. 2: Molecular Diagnostics Segment Breakup-Value: 2008
Figure II. 3: Molecular Diagnostics Segment Breakup-Percentage: 2008
Figure III. 1: Global HPV industry Size (Value): from 2003 to 2008
Figure III. 2: Global HPV industry Size (Value) Projection : from 2009 to 2015
Figure III. 3: Global HPV industry Potential by Region
Figure III. 4: Global HPV screening industry by region – Penetrated and un-penetrated
Figure III. 5: Cancer: Incidence & Deaths – US (2008)
Figure III. 6: Indian molecular diagnostics industry : 2007 - 2009
Figure IV. 1: US Cancer Molecular Diagnostics Industry : from 2006 to 2012
Figure IV. 2: Incidence and mortality – severe sepsis
Figure IV. 3: Revenues potential of sepsis tests
Figure V. 1: Molecular diagnostics versus traditional tests – Cost comparison
Figure V. 2: Top-10 Molecular Tests - US
Figure VI. 1: Industry share of leading Players – Global IVD Industry : 2008
Figure VI. 2: Global Molecular Diagnostics Industry Share: Firms - 2008
Figure VI. 3: US Molecular Diagnostics Industry Share: Firms –2007 vs. 2008
Figure VII. 1: Roche Diagnostics – Revenues by sub-segment: 2008
Figure VII. 2: Qiagen – Revenues by product group (2008)
Figure VII. 3: Abbott – Revenues by business sector (2008)
Figure VII. 4: GenProbe – Revenues : Clinical Diagnostics & Blood Screening: 2006-08
Figure VIII. 1: Global Molecular Diagnostics Industry Projection : 2000 - 2010

List of Tables

Table I. 1: IVD industry by Technology
Table VIII. 1 Dependent & Independent Variables (2002– 2008)
Table VIII. 2 Correlation Matrix
Table VIII. 3 Model Summary – Coefficient of Determination
Table VIII. 4 Regression Coefficients Output